Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,2908 USD | -6,31% |
|
+2,72% | -36,09% |
Attività
Numero di dipendenti: 6
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Allen Baharaff
CEO | Chief Executive Officer | 59 | 01/01/00 |
Doron Cohen
DFI | Director of Finance/CFO | 57 | 01/02/22 |
Guy Nehemya
COO | Chief Operating Officer | 39 | 01/10/13 |
Liat Hayardeny
CTO | Chief Tech/Sci/R&D Officer | 57 | 07/09/16 |
Yohai Stenzler
AUD | Comptroller/Controller/Auditor | 41 | 01/06/14 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | 01/06/14 |
Carol Brosgart
BRD | Director/Board Member | 72 | 07/06/17 |
Allen Baharaff
CEO | Chief Executive Officer | 59 | 01/01/00 |
Shmuel Nir
BRD | Director/Board Member | 62 | 01/01/07 |
Amir Poshinski
BRD | Director/Board Member | 63 | 16/06/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 6 358 747 | 6 126 245 ( 96,34 %) | 0 | 96,34 % |
Coordinate società
Galmed Pharmaceuticals Ltd.
16 Abba Hillel Road
5250608, Ramat Gan
+972 3 693 8448
http://galmedpharma.com![Indirizzo Galmed Pharmaceuticals Ltd.(GLMD)](https://cdn.zonebourse.com/static/address/16000956.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-36,09% | 1,85 Mln | |
+18,43% | 124 Mrd | |
+19,81% | 114 Mrd | |
+19,48% | 25,83 Mrd | |
-23,74% | 19,42 Mrd | |
-18,10% | 16,2 Mrd | |
-19,97% | 15,31 Mrd | |
+57,08% | 14,32 Mrd | |
+7,95% | 14,31 Mrd | |
-49,33% | 14,19 Mrd |
- Borsa valori
- Azioni
- Azione GLMD
- Società Galmed Pharmaceuticals Ltd.